Fact checked by Nick Blackmer Key Takeaways Cologuard Plus, a new version of the Cologuard colorectal screening test, became ...
The Food and Drug Administration (FDA) has approved the Cologuard Plus™ test for colorectal cancer screening in adults aged 45 years and older who are at average risk for colorectal cancer. According ...
Colorectal Cancer Awareness Month is observed annually in March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. As it has done ...
ASCs are increasingly at the forefront of colorectal cancer prevention efforts, particularly as new screening technologies gain traction. Following two FDA approvals last year, many ASCs are stepping ...
It's a rite of passage we don't look forward to: Once we turn 45, it's recommended that we get a colonoscopy to screen for ...
Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...
Q. My doctor prescribed a Cologuard instead of a colonoscopy. No one mentioned how often Cologuard could result in false positive test results as mine did. So, a colonoscopy was necessary after all, ...
The Cologuard Classic by Exact Sciences has helped countless people deal with the devastating impacts of colorectal cancer. But the folks behind the tournament are always looking to do more. The ...
Repositioning to better reach the elusive 45- to 50-year-old segment of potential colon cancer screening patients, Cologuard ads have replaced people singing a version of the Sinatra standard “My Way” ...
TUCSON, Ariz. (KVOA) - The Cologuard Classic will tee off from La Paloma Country Club in just over a month. The tournament brings world-class golf to Tucson, but it's so much more than that. It raises ...
TUCSON, Ariz. — Scott Cardwell was one of 40 colon cancer survivors on the course today at La Paloma Country Club. “I felt totally healthy, and I had a tennis ball sized tumor," Cardwell said. "But, ...